Re: Isotype Controls

Frederic Preffer (preffer@HELIX.MGH.HARVARD.EDU)
Tue, 26 Mar 1996 17:03:03 -0500 (EST)

>Date: Tue, 26 Mar 1996 16:54:25
>To: Alice.L.Givan@dartmouth.edu (Alice L. Givan)
>From: Frederic Preffer <preffer@helix.mgh.harvard.edu>
>Subject: Re: Isotype Controls
>
>At 11:19 AM 3/26/96 -0500 Alice Givan wrote:
>
>
>
>-----snip-------
>Because of all these problems, I believe I have heard that the latest US
>>clinical guidelines will recommend that isotype controls are not necessary
>>(i.e. a waste of time and money ?). Perhaps some clinical people can confirm
>>this for the network.
>-------
>new message:
>
>My information, from Anne Hurley is that isotypes will NOT be recommended
in leukemia/lymphoma analysis...
>
>
`````````````````````````````````````````````````
Frederic I. Preffer
preffer@helix.mgh.harvard.edu
Department of Pathology- Cox5
100 Blossom St
Massachusetts General Hospital
Boston MA 02114
(617) 726-7481 {fax x2365}
~~~~~~~~~~~~~~~~~~~~~~~~~~~

Home Page Table of Contents Sponsors Web Sites
CD ROM Vol 2 was produced by staff at the Purdue University Cytometry Laboratories and distributed free of charge as an educational service to the cytometry community. If you have any comments please direct them to Dr. J. Paul Robinson, Professor & Director, PUCL, Purdue University, West Lafayette, IN 47907. Phone:(317) 494-0757; FAX (317) 494-0517; Web http://www.cyto.purdue.edu EMAIL robinson@flowcyt.cyto.purdue.edu